Elixtris

Elixtris is Harkness Pharmaceuticals’ flagship anti-ageing cream, a product whose promise of youthful skin helped make the company a global force. It appears first as a polished consumer good and a marker of corporate success; later, questions about the scientific work charged to its project turn that familiar cosmetic into the center of a larger mystery. The novel makes the distance between the jar on a shop shelf and the opaque machinery behind it part of Elixtris’s significance.

Development and commercial rise

Harkness Pharmaceuticals’ dedicated research laboratory in Locarno becomes the setting for a succession of beauty products developed by Filippo Crosetti, a pharmaceutical prodigy. Elixtris is the culmination of that line: a revolutionary anti-ageing cream whose release in 2009 helps insulate the company from the economic downturn. The product is not merely a successful item in a catalogue. Its commercial impact helps establish Harkness as a major international player.

That growth is reinforced by Harkness Pharmaceuticals’ partnership with Quintagler Industries, a US conglomerate. The partnership finances acquisitions that remove a number of mid-sized competitors in North America, Europe and Asia. The account of Elixtris’s success therefore belongs to a broader account of corporate expansion: the cream generates wealth and prestige, while the resulting financial power allows the company to reshape the markets in which it operates. Its apparent simplicity as a beauty treatment stands against the scale of the business built around it.

The product in everyday life

Elixtris enters an ordinary domestic setting through the bathroom cabinet at Holly Walsh’s home. Blake finds face cream and body scrub bearing the Elixtris name among the medicines there, including cartons of Ditrimantelline manufactured by Harkness Pharmaceuticals. The juxtaposition places the cosmetic alongside a prescription treatment, but the products have distinct functions: Ditrimantelline is Holly’s medicine, while Elixtris is the beauty product. Blake’s attention to the manufacturer’s name turns a private household object into another reminder of Harkness’s reach.

The cream also appears on a pharmacy display in London, where its slick packaging presents the promise of restored youth directly to shoppers. Blake asks a woman who has just bought a jar whether it works. The woman answers with enthusiastic certainty, describing the result as transformative; Blake recognizes that word from Anna Marchant’s account of Ditrimantelline’s effect on Holly. The encounter gives Elixtris a human endorsement, but only an anecdotal one. The buyer’s conviction shows how effectively the product’s promise is received; it does not independently establish what the cream does.

This public display sharpens Blake’s questions about Harkness. Looking at the expensive goods he can afford, Blake cannot reconcile Harkness’s apparent wealth with the allegations that he has stolen money. Elixtris helps make the company’s success visible, yet visibility does not explain the conduct behind it. The product is at once evidence of commercial achievement and a prompt to ask what that achievement conceals.

The Elixtris project under scrutiny

The investigation reaches beyond the cream’s public claims to the budgets and personnel associated with its development. An email from Ingrid Denner identifies a planned meeting with Filippo Crosetti and Jane Glasson, who has been working with Harkness Pharmaceuticals under the name Astrid Townsend. The stated subject is Jane’s role in the continuing management of the Elixtris project, particularly a significant budget allocation for outside scientists. According to the email, each scientist’s first recorded point of contact with the company was Jane.

The listed specialists work in nanotechnology and bioelectronics. Ingrid notes that their expertise does not appear directly relevant to delivering a classical cosmetic and says that it requires explanation. More than twenty names are attached, including professors at universities in Europe, the United States, Canada, Australia and Japan. These details do not establish what the scientists were actually engaged to do, but they make the project’s costs and technical direction difficult to reconcile with Elixtris’s ordinary description as an anti-ageing cream.

Ingrid arranges the discussion for noon on 14 June in a symposium room at Harkness Pharmaceuticals’ headquarters in Zug. She directs that further communication with her go through her BlackBerry, a change that suggests she has reason to keep the exchange controlled. Blake connects the message to the discovery of the Sapper magnetic device, while also recognizing that Gareth Lawler may not have read the email. The evidence therefore builds suspicion through documents, names and unusual expertise, without resolving the purpose of the work.

From beauty product to narrative clue

Elixtris links the company’s public identity to a concealed strand of the investigation. Crosetti is known as the person who developed the cream, and Blake’s discovery of his connection to Jane gives an ordinary product a route into the inquiry surrounding her assumed identity and her work for Harkness Pharmaceuticals. When Don helps Blake by telephoning Crosetti at the Schweizerhof Hotel in Zürich, he is asked to keep Crosetti occupied, though Blake does not explain the plan. Crosetti’s importance to Elixtris makes him more than a named inventor: he is also a figure whose movements and communications may matter to the investigation.

The tension returns at the company’s headquarters. Jane and Crosetti enter Harkness Pharmaceuticals’ complex with Blake, and Blake asks Crosetti what he intends to do in Harkness’s office. Crosetti directs the question to Jane and makes clear that he does not want Blake involved. Jane refuses to explain their plan before they have carried it out. The exchange leaves the Elixtris project’s secrets unresolved, but confirms that its development and management are entangled with consequential decisions being made inside the company.

Elixtris thus changes meaning as the story proceeds. In a bathroom cabinet and a pharmacy display, it is a branded cream sold on the promise of transformation. In the company’s history, it is the commercial success that supports rapid growth and international acquisitions. In Ingrid’s email, it is a project whose spending on nanotechnology and bioelectronics calls for an answer. That contrast—not a proven revelation about the cream’s composition, but the widening gap between its familiar public face and the questions attached to its development—makes Elixtris a crucial object in the novel’s investigation.